Logo image
Fibrinolysis in intermediate risk pulmonary embolism: too much risk for too little reward?
Letter/Communication   Peer reviewed

Fibrinolysis in intermediate risk pulmonary embolism: too much risk for too little reward?

Paras Karmacharya, Ranjan Pathak, Madan Raj Aryal and Anthony A Donato
International journal of cardiology, v 176(3), pp 1290-1291
20 Oct 2014
PMID: 25115261

Abstract

Cohort Studies Databases, Factual - statistics & numerical data Fibrinolysis - drug effects Humans Pulmonary Embolism - diagnosis Pulmonary Embolism - drug therapy Reward Risk Factors Tissue Plasminogen Activator - administration & dosage Tissue Plasminogen Activator - adverse effects

Metrics

1 Record Views

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Cardiac & Cardiovascular Systems
Logo image